NCPA calls for House to examine mail-order Rx concerns as part of USPS probe
The National Community Pharmacists Association is urging the House Energy and Commerce Committee to broaden their investigation into delivery delays of mail order medications reportedly linked to operational changes at the U.S. Postal Service.
In a letter to the committee, NCPA stated that for years mail order has led to damaged or missing medications in some cases, expensive medication waste in others, conflicts of interest, and decreased patient choice and access to reliable pharmacy care.
“Because PBMs steer customers into mail order plans this limits patients to one pharmacy, and these captive customers are essentially unable to go elsewhere, even when the patient’s medications are delayed, lost in the mail or misdelivered,” said Karry La Violette, NCPA senior vice president of government affairs. “Problems with forced or incentivized mail order plans have been taking place for some time and too many patients have found themselves scrambling, even before added difficulties brought by the coronavirus pandemic.
“Policymakers should investigate the cost and safety of mail order prescriptions as well as the impacts of any delivery delays on drug safety and efficacy,” La Violette said. “We’re confident they will find that in many cases there are better, more reliable options – namely, patients’ neighborhood pharmacies – to help improve outcomes, protect patient choice, and control costs.”
Read NCPA’s letter to Energy and Commerce Committee leaders here.
Review NCPA’s Waste Not, Want Not photo display documenting the problem of medication waste associated with mail order pharmacies.